Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.
Ding L, Chen X, Zhang W, Dai X, Guo H, Pan X, Xu Y, Feng J, Yuan M, Gao X, Wang J, Xu X, Li S, Wu H, Cao J, He Q, Yang B.
Ding L, et al.
J Clin Invest. 2023 Jan 3;133(1):e154754. doi: 10.1172/JCI154754.
J Clin Invest. 2023.
PMID: 36594471
Free PMC article.